과제정보
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2021-R1F1A1045544, 2021-R1A4A1031574).
참고문헌
- Abrams P, Andersson KE. Muscarinic receptor antagonists for over-active bladder. BJU Int. 2007;100:987-1006. https://doi.org/10.1111/j.1464-410X.2007.07205.x
- Andersson KE, Campeau L, Olshansky B. Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol. 2011;72:186-196. https://doi.org/10.1111/j.1365-2125.2010.03813.x
- Ellsworth P, Berriman SJ, Brodsky M. Fesoterodine: a new agent for treating overactive bladder. Am J Manag Care. 2009;15(4 Suppl):S115-S117.
- Vella M, Cardozo L. Review of fesoterodine. Expert Opin Drug Saf. 2011;10:805-808. https://doi.org/10.1517/14740338.2011.591377
- Kuzmin IV, Al-Shukri SK. Fesoterodine for the treatment of overactive bladder: pharmacological bases and clinical results. Urol Rep. 2020;10:163-171.
- Patel N, Wisniowska B, Polak S. Virtual thorough QT (TQT) trial-extrapolation of in vitro cardiac safety data to in vivo situation using multi-scale physiologically based ventricular cell-wall model exemplified with tolterodine and fesoterodine. AAPS J. 2018;20:83.
- Dogan MF, Yildiz O, Arslan SO, Ulusoy KG. Potassium channels in vascular smooth muscle: a pathophysiological and pharmacological perspective. Fundam Clin Pharmacol. 2019;33:504-523. https://doi.org/10.1111/fcp.12461
- Kim HS, Li H, Kim HW, Shin SE, Seo MS, An JR, Ha KS, Han ET, Hong SH, Choi IW, Choi G, Lee DS, Park WS. Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. Korean J Physiol Pharmacol. 2017;21:415-421. https://doi.org/10.4196/kjpp.2017.21.4.415
- Ko EA, Park WS, Firth AL, Kim N, Yuan JX, Han J. Pathophysiology of voltage-gated K+ channels in vascular smooth muscle cells: modulation by protein kinases. Prog Biophys Mol Biol. 2010;103:95-101. https://doi.org/10.1016/j.pbiomolbio.2009.10.001
- Nieves-Cintron M, Syed AU, Nystoriak MA, Navedo MF. Regulation of voltage-gated potassium channels in vascular smooth muscle during hypertension and metabolic disorders. Microcirculation. 2018;25:e12423.
- Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol. 2001;21:28-38. https://doi.org/10.1161/01.ATV.21.1.28
- Park WS, Firth AL, Han J, Ko EA. Patho-, physiological roles of voltage-dependent K+ channels in pulmonary arterial smooth muscle cells. J Smooth Muscle Res. 2010;46:89-105. https://doi.org/10.1540/jsmr.46.89
- Cook NS. Effect of some potassium channel blockers on contractile responses of the rabbit aorta. J Cardiovasc Pharmacol. 1989;13:299-306. https://doi.org/10.1097/00005344-198902000-00019
- Yuan XJ. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+ ]i in pulmonary arterial myocytes. Circ Res. 1995;77:370-378. https://doi.org/10.1161/01.RES.77.2.370
- Bubolz AH, Li H, Wu Q, Liu Y. Enhanced oxidative stress impairs cAMP-mediated dilation by reducing Kv channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol. 2005;289:H1873-H1880. https://doi.org/10.1152/ajpheart.00357.2005
- Jackson WF. KV channels and the regulation of vascular smooth muscle tone. Microcirculation. 2018;25:e12421.
- Lin ZY, Chen LM, Zhang J, Pan XD, Zhu YG, Ye QY, Huang HP, Chen XC. Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacol Sin. 2012;33:438-444. https://doi.org/10.1038/aps.2011.181
- Wu SN, Hsu MC, Liao YK, Wu FT, Jong YJ, Lo YC. Evidence for in-hibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evid Based Comple- ment Alternat Med. 2012;2012:148403.
- Ney P, Pandita RK, Newgreen DT, Breidenbach A, Stohr T, Andersson KE. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. BJU Int. 2008;101:1036-1042. https://doi.org/10.1111/j.1464-410X.2007.07358.x
- Seo MS, An JR, Jung HS, Jung WK, Choi IW, Na SH, Park H, Bae YM, Park WS. The muscarinic receptor antagonist tolterodine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Eur J Pharmacol. 2020;870:172921.
- Li H, Seo MS, An JR, Jung HS, Ha KS, Han ET, Hong SH, Bae YM, Ryu DR, Park WS. The anticholinergic drug oxybutynin inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. Clin Exp Pharmacol Physiol. 2019;46:1030-1036. https://doi.org/10.1111/1440-1681.13138
- Seo MS, An JR, Jung HS, Kang M, Heo R, Han ET, Yang SR, Park H, Jung WK, Choi IW, Bae YM, Na SH, Park WS. Suppression of volt-age-gated K+ channels by darifenacin in coronary arterial smooth muscle cells. Eur J Pharmacol. 2021;891:173707.
- Smirnov SV, Tammaro P, Hutchings SR, Smith AL. Role of voltage-gated K+ (Kv) channels in vascular function. Neurophysiology. 2003;35:234-247. https://doi.org/10.1023/B:NEPH.0000008784.83366.9a
- Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Animal models of cardiovascular diseases. J Biomed Biotechnol. 2011;2011:497841.
- Morales-Cano D, Moreno L, Barreira B, Pandolfi R, Chamorro V, Jimenez R, Villamor E, Duarte J, Perez-Vizcaino F, Cogolludo A. Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia. Cardiovasc Res. 2015;106:98-108. https://doi.org/10.1093/cvr/cvv020
- Thorneloe KS, Chen TT, Kerr PM, Grier EF, Horowitz B, Cole WC, Walsh MP. Molecular composition of 4-aminopyridine-sensitive voltage-gated K+ channels of vascular smooth muscle. Circ Res. 2001;89:1030-1037. https://doi.org/10.1161/hh2301.100817
- Li Q, Zhang R, Lu CL, Liu Y, Wang Z, Zhu DL. [The role of subtypes of voltage-gated K+ channels in pulmonary vasoconstriction induced by 15-hydroeicosatetraenoic acid]. Yao Xue Xue Bao. 2006;41:412-417. Chinese.
- Stott JB, Povstyan OV, Carr G, Barrese V, Greenwood IA. G-protein βγ subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity. Proc Natl Acad Sci U S A. 2015;112:6497-6502. https://doi.org/10.1073/pnas.1418605112
- Mani BK, Robakowski C, Brueggemann LI, Cribbs LL, Tripathi A, Majetschak M, Byron KL. Kv7.5 potassium channel subunits are the primary targets for PKA-dependent enhancement of vascular smooth muscle Kv7 currents. Mol Pharmacol. 2016;89:323-334. https://doi.org/10.1124/mol.115.101758
- An JR, Li H, Seo MS, Park WS. Inhibition of voltage-dependent K+ current in rabbit coronary arterial smooth muscle cells by the class Ic antiarrhythmic drug propafenone. Korean J Physiol Pharmacol. 2018;22:597-605 https://doi.org/10.4196/kjpp.2018.22.5.597